Portfolio 2008

Company: Okapi Sciences N.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2008
Status: Realized

Okapi develops antiviral drug products to treat viral diseases in pet animals and livestock. The company was acquired by Aratana Therapeutics Inc.

Company: Bioceros B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2008
Status: Realized

Bioceros is active in the field of protein therapeutics, and offers producer cell line generation services; it also aims to develop an own therapeutic monoclonal antibody pipeline. Our position was sold to a strategic investor.

Company: argenx b.v. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2008
Status: Active

argenx is monoclonal antibody company employing proprietory superior therapeutic antibody discovery platform to develop own antibody product portfolio.